Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.

Overview of attention for article published in Antimicrobial Agents and Chemotherapy, September 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 58 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 4,091 followers.

Be aware....one single change in amino acid sequence produces DANGEROUS SUPERBUGS... In vivo evolution of resistance described by @GonzalezBello_C at @ciqususc @UniversidadeUSC. Read more... https://t.co/zErnYa5yl2

27 Sep 2019

Reply Repost Favourite

RT @pseudo_papers: Challenging antimicrobial susceptibility and evolution of resistance (OXA-681) during treatment of a Pseudomonas aerugin…

23 Aug 2019

Reply Repost Favourite

Challenging antimicrobial susceptibility and evolution of resistance (OXA-681) during treatment of a Pseudomonas aeruginosa ST175 clone long-term nosocomial infection. https://t.co/sqmwuV5nAI

07 Aug 2019

Reply Repost Favourite

OXA-2 oksilinazını tedavi ederken ortaya yeni OXA-681 çıkmıştır. Bu enzim yeni sefalosporin / ß-laktamaz inhibitör kombinasyonlarına karşı yükseltilmiş MİK'ler vermektedir. https://t.co/pIkXszDB62

06 Aug 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.